Loading...

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

2196.HKHKSE
HealthcareDrug Manufacturers - Specialty & Generic
HK$16.60
HK$0.60(3.75%)

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) Company Profile & Overview

Explore Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) Company Profile & Overview

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Deyong Wen

Contact Information

86 21 3398 7000
Building A, Shanghai, 200233

Company Facts

40,557 Employees
IPO DateOct 30, 2012
CountryCN
Actively Trading

Frequently Asked Questions